Literature DB >> 9819212

Activating a zymogen without proteolytic processing: mutation of Lys15 and Asn194 activates trypsinogen.

A Pasternak1, X Liu, T Y Lin, L Hedstrom.   

Abstract

The zymogen and mature enzyme forms of trypsin-like serine proteases exhibit a wide range of activities. The prototypical trypsinogen-trypsin system is an example of a minimally active zymogen and a maximally active mature protease. The present work identifies several features of trypsinogen which govern its activity. Our results indicate that rat trypsin is 10(8)-fold more active than rat trypsinogen. Rat trypsinogen appears to be less active than bovine trypsinogen. His40 is believed to be an important determinant of zymogen activity. We are unable to verify this role for His40 in trypsinogen since the mutation of His40 to Phe appears to change the trypsin-substrate interface. Deletion of the N-terminal Ile16 from trypsin is expected to produce a trypsinogen-like protein since the Ile16-Asp194 salt bridge cannot form. Such mutants have higher activity and BPTI affinity than trypsinogen, which indicates that the activation peptide stabilizes the inactive trypsinogen conformation. The mutation of Lys15 to Ala increases the BPTI affinity and activity of trypsinogen to an even greater extent; thus, removal of Lys15 can account for the effect of the loss of the activation peptide. These results suggest that Lys15 is an important determinant of zymogen activity. The mutation of Asp194 to Asn also increases the BPTI affinity and activity of trypsinogen. This result suggests that in addition to stabilizing the active conformation of trypsin via the Ile16-Asp194 salt bridge, Asp194 also maintains the inactive conformation of trypsinogen. A correlation exists between the values of kcat/Km and BPTI affinity of mutant trypsinogens and trypsins. However, the slope of this correlation is 0.64, which indicates that different "active" conformations are involved in BPTI binding and substrate hydrolysis. DeltaI16V17 trypsinogen is the lone outlier; its BPTI affinity is higher than would be expected based on the value of kcat/Km. We show that the rate of BPTI association is slower for DeltaI16V17 trypsinogen than for a mutant trypsinogen with a similar BPTI affinity. This observation suggests that BPTI binds to an "active" trypsinogen conformation that is not kinetically accessible to substrates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819212     DOI: 10.1021/bi980951d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  The energetic cost of induced fit catalysis: Crystal structures of trypsinogen mutants with enhanced activity and inhibitor affinity.

Authors:  A Pasternak; A White; C J Jeffery; N Medina; M Cahoon; D Ringe; L Hedstrom
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

2.  Short-lived protease serpin complexes: partial disruption of the rat trypsin active site.

Authors:  Lu Liu; Nicole Mushero; Lizbeth Hedstrom; Anne Gershenson
Journal:  Protein Sci       Date:  2007-11       Impact factor: 6.725

3.  Activation mechanism of recombinant Der p 3 allergen zymogen: contribution of cysteine protease Der p 1 and effect of propeptide glycosylation.

Authors:  Marie-Eve Dumez; Nathalie Teller; Frédéric Mercier; Tetsuya Tanaka; Isabel Vandenberghe; Michel Vandenbranden; Bart Devreese; André Luxen; Jean-Marie Frère; André Matagne; Alain Jacquet; Moreno Galleni; Andy Chevigné
Journal:  J Biol Chem       Date:  2008-08-25       Impact factor: 5.157

4.  Comparison of anionic and cationic trypsinogens: the anionic activation domain is more flexible in solution and differs in its mode of BPTI binding in the crystal structure.

Authors:  A Pasternak; D Ringe; L Hedstrom
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

5.  Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist.

Authors:  Daniel Kirchhofer; Michael T Lipari; Lydia Santell; Karen L Billeci; Henry R Maun; Wendy N Sandoval; Paul Moran; John Ridgway; Charles Eigenbrot; Robert A Lazarus
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

6.  Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen.

Authors:  Zsófia Nemoda; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2006-02-27       Impact factor: 5.157

7.  Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity.

Authors:  Henry R Maun; Charles Eigenbrot; Helga Raab; David Arnott; Lilian Phu; Sherron Bullens; Robert A Lazarus
Journal:  Protein Sci       Date:  2005-05       Impact factor: 6.725

8.  Non-canonical proteolytic activation of human prothrombin by subtilisin from Bacillus subtilis may shift the procoagulant-anticoagulant equilibrium toward thrombosis.

Authors:  Giulia Pontarollo; Laura Acquasaliente; Daniele Peterle; Roberta Frasson; Ilaria Artusi; Vincenzo De Filippis
Journal:  J Biol Chem       Date:  2017-07-06       Impact factor: 5.157

9.  A novel mode of intervention with serine protease activity: targeting zymogen activation.

Authors:  Grant E Blouse; Kenneth A Bøtkjaer; Elena Deryugina; Aleksandra A Byszuk; Janni M Jensen; Kim K Mortensen; James P Quigley; Peter A Andreasen
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

10.  The conformational switch from the factor X zymogen to protease state mediates exosite expression and prothrombinase assembly.

Authors:  Raffaella Toso; Hua Zhu; Rodney M Camire
Journal:  J Biol Chem       Date:  2008-05-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.